VASCULAR INJURY AND TIME COURSE OF SMOOTH-MUSCLE CELL-PROLIFERATION AFTER EXPERIMENTAL HOLMIUM LASER ANGIOPLASTY

被引:24
|
作者
HASSENSTEIN, S [1 ]
HANKE, H [1 ]
KAMENZ, J [1 ]
OBERHOFF, M [1 ]
HANKE, S [1 ]
RIESSEN, R [1 ]
HAASE, KK [1 ]
BETZ, E [1 ]
KARSCH, KR [1 ]
机构
[1] UNIV TUBINGEN,DEPT PHYSIOL 1,W-7400 TUBINGEN 1,GERMANY
关键词
SMOOTH MUSCLE CELLS; HOLMIUM LASER; BROMODEOXYURIDINE; ATHEROSCLEROSIS; LASERS; ANGIOPLASTY;
D O I
10.1161/01.CIR.86.5.1575
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. In vitro experiments have shown that holmium laser energy can effectively ablate even calcified plaque in human arterial vessels. Because high-energy densities from holmium lasers can easily be transmitted through quartz fibers, this solid-state laser has been suggested as an alternative intraluminal treatment of atherosclerotic plaque. Methods and Results. To develop an intimal plaque, 35 New Zealand White rabbits underwent electrical stimulation of their right carotid artery for 28 days. Subsequently, in 25 rabbits, holmium laser angioplasty (wavelength, 2.12 mum; pulse duration, 150 musec; energy density, 350 mJ/mm2) was performed. To study the morphological results, the vessels were excised after 7, 14, 28, and 42 days. Cross sections were analyzed in regard to laser-specific injury. Staining of alpha-actin was used to identify smooth muscle cells (SMCs). After bromodeoxyuridine labeling, the extent of proliferation (number of cells undergoing DNA synthesis) was determined by using a monoclonal antibody. Holmium laser ablation resulted in an initial decrease of the numbers of intimal cell layers in the early group (7 days after treatment: 5+/-1 cell layers with 76+/-39 mum; control: 13+/-3 cell layers with 144+/-44 mum). Quantification of SMCs undergoing DNA synthesis in the intima (control: 51+/-19 cells/mm2) showed a significant increase of labeled cells after 7 (216+/-74 cells/mm2, p=0.003) and 14 days (281+/-139 cells/mm, p=0.011). Integrity of the internal elastic lamina was disrupted in all animals after intervention. Seven and 14 days after treatment, a considerable reduction of medial cell nuclei was found in 10 of 12 animals. SMC proliferation in the medial layer was increased within the first 2 weeks after laser ablation (168+/-113 cells/mm2; control: 8+/-4 cells/mm2; p=0.023). Six weeks after holmium laser angioplasty, SMC proliferation had returned to control levels in the intima and remained increased in the medial layer. This proliferative response resulted in a significant increase of intimal thickening within 6 weeks after laser ablation (30+/-6 cell layers, 375 +/- 97 mum resp.; p =0.001 each). Conclusions. Holmium laser treatment leads to considerable vessel wall injury and results in SMC proliferation in the intimal and medial layer with a maximum of proliferative activity within the first 2 weeks. Subsequently, this results in considerable intimal and medial hyperplasia within 6 weeks after treatment.
引用
收藏
页码:1575 / 1583
页数:9
相关论文
共 50 条
  • [31] Site-specific delivery of iloprost during experimental angioplasty suppresses smooth muscle cell proliferation
    Kandarpa, K
    Nakatsuka, S
    Yousuf, N
    Barry, JJ
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1998, 9 (03) : 487 - 493
  • [32] PROMOTION OF AORTIC SMOOTH-MUSCLE CELL-PROLIFERATION BY HYPERCHOLESTEROLEMIC LDL AND ITS SUPPRESSION BY HEPARIN OR SULFATED GLYCOSAMINOGLYCANS
    TASAKI, H
    NAKASHIMA, Y
    SEGAWA, J
    KOUZUMA, R
    KUROIWA, A
    SPARKS, DL
    TULENKO, TN
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 1994, 4 (1-2) : 57 - 71
  • [33] INVOLVEMENT OF NITRIC-OXIDE IN IFN-GAMMA-MEDIATED REDUCTION OF MICROVESSEL SMOOTH-MUSCLE CELL-PROLIFERATION
    STEIN, CS
    FABRY, Z
    MURPHY, S
    HART, MN
    MOLECULAR IMMUNOLOGY, 1995, 32 (13) : 965 - 973
  • [34] INHIBITORY EFFECTS OF A NOVEL ANTIATHEROMATOUS AGENT, E5050, ON AORTIC SMOOTH-MUSCLE CELL-PROLIFERATION, INVITRO
    SAEKI, T
    TSUNODA, H
    SHIOJIRI, H
    YAMATSU, I
    MORISAKI, N
    SAITO, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 189 (01): : 23 - 29
  • [36] Syndecan-4 Deficiency Limits Neointimal Formation After Vascular Injury by Regulating Vascular Smooth Muscle Cell Proliferation and Vascular Progenitor Cell Mobilization
    Ikesue, Masahiro
    Matsui, Yutaka
    Ohta, Daichi
    Danzaki, Keiko
    Ito, Koyu
    Kanayama, Masashi
    Kurotaki, Daisuke
    Morimoto, Junko
    Kojima, Tetsuhito
    Tsutsui, Hiroyuki
    Uede, Toshimitsu
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (05) : 1066 - U310
  • [37] RABBIT AORTIC SMOOTH-MUSCLE CELL-CULTURE - A MODEL FOR THE PHARMACOLOGICAL STUDY OF DIABETES-INDUCED ALTERATIONS IN CELL-PROLIFERATION
    ALIPUI, C
    TENNER, TE
    RAMOS, K
    JOURNAL OF PHARMACOLOGICAL METHODS, 1991, 26 (03): : 211 - 222
  • [38] Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury
    Ogita, Manabu
    Miyauchi, Katsumi
    Jiang, Meizi
    Kasai, Takatoshi
    Tsuboi, Shuta
    Naito, Ryo
    Konishi, Hirokazu
    Dohi, Tomotaka
    Yokoyama, Takayuki
    Okazaki, Shinya
    Shimada, Kazunori
    Bujo, Hideaki
    Daida, Hiroyuki
    ATHEROSCLEROSIS, 2014, 237 (01) : 374 - 378
  • [39] EFFECT OF MK-571, A SELECTIVE LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND INTERLEUKIN-1 RELEASE
    PORRECA, E
    REALE, M
    DIFEBBO, C
    BARBACANE, RC
    CASTELLANI, ML
    CIPOLLONE, F
    CARRATELLI, L
    CONTI, P
    CUCCURULLO, F
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1994, 7 (01) : 57 - 64
  • [40] INHIBITION OF SMOOTH-MUSCLE CELL-PROLIFERATION IN INJURED RAT ARTERIES - INTERACTION OF HEPARIN WITH BASIC FIBROBLAST GROWTH-FACTOR
    LINDNER, V
    OLSON, NE
    CLOWES, AW
    REIDY, MA
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) : 2044 - 2049